Steven Hutchins is a Cardiology physician affiliated with Abbott. OpenAlex indexes 8 publications with 1,754 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9500 Kanis Rd
Suite 410
Little Rock, AR 722056324
Telephone
501-202-4936Provider last certified this registry record 20 Jul 2020.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20251 payment
- Merck Sharp & Dohme LLCProgram year20251 payment
- Alnylam Pharmaceuticals Inc.Program year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
60.1%Beta blocker12.3%Metoprolol Succinate55%Carvedilol39%Metoprolol Tartrate3%Atenolol3%Part D<11 patientsStatin10.3%Atorvastatin Calcium46%Rosuvastatin Calcium36%Pravastatin Sodium14%Simvastatin5%Part D<11 patients+ 16 more classes in this area
Metabolism & gastrointestinal
15.6%Potassium supplement4.9%Potassium Chloride82%Klor-Con M2018%Part D≥43 patientsSGLT2 inhibitor4.4%Jardiance100%Part D≥28 patients+ 7 more classes in this area
Blood & clotting
7.1%Factor Xa inhibitor4.8%Eliquis67%Xarelto33%Part D<11 patientsVitamin K antagonist1.3%Warfarin Sodium100%Part D≥14 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report
New England Journal of Medicine
2019 - Open partnering of integrated drug discovery: continuing evolution of the pharmaceutical model
Drug Discovery Today
2011 - Levosimendan rapidly lowers plasma endothelin-1 and TNF-alpha levels in patients with severe heart failure
Journal of Cardiac Failure
1999
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”